Chronic Obstructive Pulmonary Disease Process

Chronic obstructive pulmonary disease (COPD) is one of the commonest lung disorders that is associated with smoking. It is typically characterized by chronic airflow obstruction and difficulty in breathing.

Along with difficulty in breathing there are several pathological changes in the lung (pulmonary) as well as some significant effects on the whole body (extra-pulmonary effects) and presence of co-existing ailments. These all contribute to the severity of the disease in individual patients.

Definition of COPD

According to the World Health Organization, “Chronic Obstructive Pulmonary Disease (COPD) is a preventable and treatable disease with some significant extra-pulmonary effects that may contribute to the severity in individual patients.”

The definition suggests that the airway obstruction is not fully reversible. There is a progressive damage to the airflow due to inflammation in the airways.

Local pathology of COPD

Smoking is the most important causative factor associated with COPD. At least four out of five people with COPD have a history of being smokers in the past or are smokers at present.

Cigarette smoke contains harmful chemicals that cause irritation in the inner lining and walls of the airways. This leads to inflammation of the walls. The inflammation and damage leads to scarring and deformities of the air sacs and narrow air passages. This is called emphysema and leads to loss of elasticity of the lung tissues that is essential for breathing and oxygen extraction from the inhaled air. This damage caused to the airways by cigarette smoke cannot be reversed and smokers even after quitting continue to have a higher risk of developing COPD.

Around 10-25% of smokers develop COPD. Approximately 80 to 90 percent of COPD deaths are caused by smoking. Female smokers are nearly 13 times as likely to die from COPD as women who have never smoked. On the other hand male smokers are nearly 12 times as likely to die from COPD as males who have never smoked.

Airway obstruction pathology in COPD

The airway obstruction that is characteristic of COPD is caused by a mixture of small airway disease called obstructive bronchiolitis as well as due to damage and destruction of the lung tissues or lung parenchyma in a process called emphysema. The relative proportions of these two pathologies are different in different individuals.

Destruction of the lung parenchyma caused due to inflammation also leads to loss of alveolar attachments to the smaller airways that reduces the elasticity of the lung tissues, this prevents the airways from remaining open while breathing out. Airflow limitation is best measured by spirometry.

Chronic bronchitis refers to the presence of cough and sputum production for at least 3 months in two consecutive years. It forms a part of COPD diagnosis along with emphysema.

COPD and other ailments

COPD may often co-exist with other ailments. This may be because most COPD patients are long term smokers in their middle ages. They may thus have other diseases associated with smoking and aging as well.

Studies have shown that up to 25% of the population 65 years and older may develop at least two co-existing ailments and up to 17% have three coexisting ailments along with COPD.

Some of the common associated diseases that may be seen among COPD patients include:-

  • Respiratory infections that may be frequent and recurrent
  • Heart attacks or myocardial infarction
  • Angina or chest pain during exertion
  • Osteoporosis or brittle bones leading to easy fractures
  • Depression
  • Diabetes
  • Sleep disorders
  • Glaucoma of the eyes
  • Anemia
  • Lung cancer

Some of the common problems that that may be seen among COPD patients include:-

  • Nutritional deficiencies
  • Weight loss
  • Muscle weakness

Development of COPD

COPD is generally a progressive disease especially if the patient continues to be exposed to cigarette smoke and other noxious fumes.

Stopping exposure to these agents may result in some improvement in lung function and slow the progression of the disease.



Further Reading

Last Updated: Jul 3, 2023

Dr. Ananya Mandal

Written by

Dr. Ananya Mandal

Dr. Ananya Mandal is a doctor by profession, lecturer by vocation and a medical writer by passion. She specialized in Clinical Pharmacology after her bachelor's (MBBS). For her, health communication is not just writing complicated reviews for professionals but making medical knowledge understandable and available to the general public as well.


Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Mandal, Ananya. (2023, July 03). Chronic Obstructive Pulmonary Disease Process. News-Medical. Retrieved on June 16, 2024 from

  • MLA

    Mandal, Ananya. "Chronic Obstructive Pulmonary Disease Process". News-Medical. 16 June 2024. <>.

  • Chicago

    Mandal, Ananya. "Chronic Obstructive Pulmonary Disease Process". News-Medical. (accessed June 16, 2024).

  • Harvard

    Mandal, Ananya. 2023. Chronic Obstructive Pulmonary Disease Process. News-Medical, viewed 16 June 2024,


The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Heavy menstrual bleeding raises heart disease risk in young women